These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 28936829)
1. [Protocol of intensive hospital monitoring with long follow up and large sample: Diemailing Kudiezi injection as example]. Liao X; Xie YM; Wang GQ Zhongguo Zhong Yao Za Zhi; 2016 Dec; 41(24):4494-4499. PubMed ID: 28936829 [TBL] [Abstract][Full Text] [Related]
2. [Post-marketing safety surveillance of Diemailing Kudiezi injection: real world study in 30 233 cases]. Liao X; Yu DD; Xie YM; Zhang YL; He Y; Zhang Y; Liu Y; Yi DH; Wang YY Zhongguo Zhong Yao Za Zhi; 2017 Aug; 42(15):2857-2863. PubMed ID: 29139248 [TBL] [Abstract][Full Text] [Related]
3. [Clinical comprehensive evaluation of Diemailing~® Kudiezi Injection in treatment of cerebral infarction]. Liu FM; Xie YM; Wang ZF; Zhang Q; Cui X Zhongguo Zhong Yao Za Zhi; 2021 Dec; 46(23):6105-6113. PubMed ID: 34951238 [TBL] [Abstract][Full Text] [Related]
4. [Analysis of Diemailing Kudiezi injection use in real world in 7 189 patients with cerebral infarction]. Liao X; Zhang Y; Xie YM; Liu Y; Yi DH; Zhang YL; Chen F Zhongguo Zhong Yao Za Zhi; 2016 Dec; 41(23):4442-4450. PubMed ID: 28933125 [TBL] [Abstract][Full Text] [Related]
5. [Systematic review of Kudiezi injection drug safety]. Gao SS; Cui RZ; Xie YM; Liao X; Gao XY; Wang JD Zhongguo Zhong Yao Za Zhi; 2017 Jun; 42(12):2380-2390. PubMed ID: 28822197 [TBL] [Abstract][Full Text] [Related]
6. [Editorial explanation for Expert consensus statement on Diemailing Kudiezi Injection in clinical practice]. Liao X; Zhang YL; Xie YM; Shi DZ; Yu DD Zhongguo Zhong Yao Za Zhi; 2019 Sep; 44(17):3825-3829. PubMed ID: 31602959 [TBL] [Abstract][Full Text] [Related]
7. [Expert consensus statement on Diemailing~® Kudiezi Injection in clinical practice]. Liao X; Zhang YL; Xie YM; Shi DZ; Sun SL; Zou YH; Li J; Lu WX; Jin M; Liu HX; Tang XC; Jin XL; Ma YZ; Zhan SY; Liu JP; Chen YL Zhongguo Zhong Yao Za Zhi; 2019 Jul; 44(14):2926-2931. PubMed ID: 31602834 [TBL] [Abstract][Full Text] [Related]
8. [Analysis of questionable allergic factors to kudiezi injection--nested case control study using hospital information system data]. Liao X; Zeng XB; Xie YM; Yang W; Ai QH Zhongguo Zhong Yao Za Zhi; 2014 Sep; 39(18):3559-62. PubMed ID: 25532395 [TBL] [Abstract][Full Text] [Related]
9. Safety of traditional Chinese medicine injection based on spontaneous reporting system from 2014 to 2019 in Hubei Province, China. Huang R; Cai Y; Yang L; Shangguan X; Ghose B; Tang S Sci Rep; 2021 Apr; 11(1):8875. PubMed ID: 33893351 [TBL] [Abstract][Full Text] [Related]
10. Safety profile of traditional Chinese herbal injection: An analysis of a spontaneous reporting system in China. Li H; Deng J; Deng L; Ren X; Xia J Pharmacoepidemiol Drug Saf; 2019 Jul; 28(7):1002-1013. PubMed ID: 31131950 [TBL] [Abstract][Full Text] [Related]
11. [Discussion on establishment of quality control system for intensive hospital monitoring on traditional Chinese medicine injections]. Jiang JJ; Xie YM Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2689-91. PubMed ID: 23285909 [TBL] [Abstract][Full Text] [Related]
12. Safety of the Xuesaitong injection in China: results from a large-scale multicentre post-marketing surveillance study in a real-world setting. He Y; Gao XM; Li L; Liu XG; Liu W; Hong XJ; Huang BH; Yang HL; Xue MH; Wu XJ; Liu JF Curr Med Res Opin; 2020 Dec; 36(12):1947-1953. PubMed ID: 33016133 [TBL] [Abstract][Full Text] [Related]
13. [Interpretation of adverse drug reaction reporting and monitoring and significance of traditional Chinese medicine adverse drug reaction monitoring]. Wang D; Du XX Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2686-8. PubMed ID: 23285908 [TBL] [Abstract][Full Text] [Related]
14. Clinical effect of Kudiezi injection on renal function based on propensity score. Zhang ZK; Yang W; Liu H; Zeng XB; Zhuang Y; Xie YM Zhongguo Zhong Yao Za Zhi; 2015 Jul; 40(13):2661-7. PubMed ID: 26697696 [TBL] [Abstract][Full Text] [Related]
15. [Research on establishment of clinical safety intensive hospital monitoring net of traditional Chinese medicine injection]. Wang LX; Xie YM; Wang ZF Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2692-4. PubMed ID: 23285910 [TBL] [Abstract][Full Text] [Related]
16. [Post-marketing re-evaluation of Kudiezi injection study on early treatment in patients with ischemic stroke]. Ye X; Wei X; Xie Y; Zou Y; Zhao X; Han J; Wang X; Ma Y; Bi Q; Xie Q; Zhao J; Cao X; Chen H; Wang S; Yan R; Han Z; Yi D; Wang Y Zhongguo Zhong Yao Za Zhi; 2011 Oct; 36(20):2793-5. PubMed ID: 22292367 [TBL] [Abstract][Full Text] [Related]
17. Post-marketing safety surveillance and re-evaluation of Xueshuantong injection. Li C; Xu T; Zhou P; Zhang J; Guan G; Zhang H; Ling X; Li W; Meng F; Liu G; Lv L; Yuan J; Li X; Zhu M BMC Complement Altern Med; 2018 Oct; 18(1):277. PubMed ID: 30326892 [TBL] [Abstract][Full Text] [Related]
18. [Retrospective analysis and discussion on 74 cases of adverse reactions of traditional Chinese medicine injection]. Wang Y; Fan LP; Song J; Cai YP; Jinang TT; Wang YG; Kong XW; Wu JR Zhongguo Zhong Yao Za Zhi; 2018 Nov; 43(21):4347-4351. PubMed ID: 30583639 [TBL] [Abstract][Full Text] [Related]
19. [32 546 intensive hospital monitoring cases of Shuxuetong injection]. Jiang JJ; Xie YM; Zhang Y; Yang ZX; Yi DH Zhongguo Zhong Yao Za Zhi; 2016 Oct; 41(20):3852-3858. PubMed ID: 28929666 [TBL] [Abstract][Full Text] [Related]
20. [Necessity of applying pharmacovigilance in post-marketing safety monitoring of traditional Chinese medicine injections]. Wang HN; Chen W; Fu Z; Du WM; He J Zhongguo Zhong Yao Za Zhi; 2008 Mar; 33(5):612-4. PubMed ID: 18536393 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]